Identifying Natural Derived Upregulators of Human ApoA-I Expression via a Cell-Based Drug Screening System-Reference-Cited by-同舟云学术

Identifying Natural Derived Upregulators of Human ApoA-I Expression via a Cell-Based Drug Screening System

Published:2008-01 Issue:9 Volume:46 Page:610-615
ISSN:1388-0209
Container-title:Pharmaceutical Biology
language:en
Short-container-title:Pharmaceutical Biology

Author:

Deng Ting¹,Ji Wei¹,Lian Ji-Hong¹,Guo Lei¹,Hu Wei-Rong¹,Qian Ming¹,Gong Bang-qiang¹

Affiliation:

1. Department of Biochemistry and Bioengineering, College of Bioengineering, East China University of Science and Technology, Shanghai, People's Republic of China

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13880200802179584

Reference30 articles.

1. G Assmann, AV Eckardstein, and HB Brewer. The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill, New York, (2001)2937–2980.

2. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.

3. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.

4. Structural models of human apolipoprotein A-I: a critical analysis and review

5. Effect of dietary fat saturation on plasma lipoproteins and high density lipoprotein metabolism of the rhesus monkey.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The water extract of Radix scutellariae, its total flavonoids and baicalin inhibited CYP7A1 expression, improved bile acid, and glycolipid metabolism in T2DM mice;Journal of Ethnopharmacology;2022-07

2. High-density lipoprotein-based drug discovery for treatment of atherosclerosis;Expert Opinion on Drug Discovery;2015-05-28

3. How can high-throughput screening deliver drugs to treat atherosclerosis?;Expert Opinion on Drug Discovery;2010-11-20

4. Synthesis of 2-aryl-4H-pyrano[2,3-b]pyridin-4-ones by a one-pot deprotection–cyclization reaction;Tetrahedron;2009-08